Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tesseract Life Sciences is a private health and life sciences company focused on nutrient delivery, engineered ingredients, and commercial supplements rather than traditional prescription therapeutics. The company describes itself as the patent and technology hub for subsidiaries including Tesseract Medical Research, BioTess, and Advanced Powder Dynamics, and it develops particle engineering and delivery technologies intended to improve bioavailability, absorption, palatability, and formulation performance. Its commercial portfolio spans branded ingredients such as CapraMax, ButyratePro, GlutathionePro, and AcetaSafe, as well as finished supplement products sold through Tesseract Medical Research. The business appears to operate at the intersection of nutraceuticals, medical foods, pharmaceutical-enabling ingredients, and formulation/manufacturing services. Based on the available public information, it is best characterized as a commercial-stage platform company in health and wellness delivery technology, not a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tesseract.